SPONSOR
Turku University Hospital
Total Trials
5
Recruiting
5
Phases
Phase 4, Phase 2, Phase 3
Conditions studied: AtherosclerosesInflammationTick Borne Encephalitis (TBE)Lyme BorreliosisNeoehrlichiosisTick-Borne DiseasesAnaplasmosisBabesiosis, HumanRickettsia InfectionsBorrelia Miyamotoi -Infection
Turku University Hospital is a clinical research sponsor with 5 registered studies on ClinicalTrials.gov, of which 5 are actively recruiting participants. Research covers conditions including Atheroscleroses, Inflammation, Tick Borne Encephalitis (TBE), Lyme Borreliosis.
The trial portfolio spans Phase 4, Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Turku University Hospital
How many clinical trials has Turku University Hospital sponsored?
ClinicalMetric currently tracks 5 clinical trials sponsored by Turku University Hospital, of which 5 are actively recruiting participants. These trials cover conditions including Atheroscleroses, Inflammation, Tick Borne Encephalitis (TBE). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Turku University Hospital research focus on?
Turku University Hospital clinical trials span Atheroscleroses, Inflammation, Tick Borne Encephalitis (TBE), Lyme Borreliosis, Neoehrlichiosis, and additional conditions. The research pipeline includes Phase 4, Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Turku University Hospital clinical trial?
To participate in a Turku University Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Turku University Hospital trials with current recruitment status updated daily.
Clinical Trials by Turku University Hospital
NCT07877324
Recruiting
Vascular Inflammation in Atherosclerosis - Whole Body Molecular PET/CT Imaging Using Folate Receptor β
Atheroscleroses
NCT07897825
Recruiting
FINtick - a Prospective Multicenter Study on Tick-borne Infections in Finland
Tick Borne Encephalitis (TBE)
NCT06974994
Recruiting
Resilience to Antibiotic-induced Obesogenic Microbiota: Discovering Mechanism of Microbiota Modulation
Healthy Newborn Infants
NCT06739473 Phase 4
Recruiting
Total-body Glucose Utilization in Obesity
Obesity and Overweight
NCT07272772 Phase 2, Phase 3
Recruiting
Colon Cancer Diagnosis With FAPI-PET Imaging
Colon Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology